Literature DB >> 17150179

Action of NF-kappaB on the delta opioid receptor gene promoter.

Yulong L Chen1, Ping-Yee Law, Horace H Loh.   

Abstract

The G protein-coupled delta opioid receptor gene (dor) is temporally and spatially expressed during development. The DOR receptor plays important roles in diverse biological processes, including pain control, immune functions, and cell survival. We previously found that PI3K/Akt/NF-kappaB signaling is important in the regulation of dor gene expression during nerve growth factor (NGF)-induced differentiation of PC12h cells, which prompted us to examine whether NF-kappaB p65 is directly or indirectly involved in the regulation of dor promoter activity. In this study, deletional and functional analysis of the dor promoter revealed a 94-bp NGF-responsive fragment upstream of the dor promoter region and involvement of NF-kappaB in regulating the promoter activity. Chromatin immunoprecipitation assays demonstrated that NF-kappaB p65 is directly bound to the dor promoter and such binding is related to NGF/PI3K signaling. Together, the results show that direct association of p65 with the promoter is important in NGF-induced dor promoter activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17150179     DOI: 10.1016/j.bbrc.2006.11.103

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  NGF/PI3K signaling-mediated epigenetic regulation of delta opioid receptor gene expression.

Authors:  Yulong L Chen; Ping-Yee Law; Horace H Loh
Journal:  Biochem Biophys Res Commun       Date:  2008-02-11       Impact factor: 3.575

Review 2.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

3.  Transcriptional Alterations in Dorsolateral Prefrontal Cortex and Nucleus Accumbens Implicate Neuroinflammation and Synaptic Remodeling in Opioid Use Disorder.

Authors:  Marianne L Seney; Sam-Moon Kim; Jill R Glausier; Mariah A Hildebrand; Xiangning Xue; Wei Zong; Jiebiao Wang; Micah A Shelton; BaDoi N Phan; Chaitanya Srinivasan; Andreas R Pfenning; George C Tseng; David A Lewis; Zachary Freyberg; Ryan W Logan
Journal:  Biol Psychiatry       Date:  2021-06-12       Impact factor: 12.810

4.  Mu-opioid signaling modulates biphasic expression of TrkB and IκBα genes and neurite outgrowth in differentiating and differentiated human neuroblastoma cells.

Authors:  Aiyun Wen; Abra Guo; Yulong L Chen
Journal:  Biochem Biophys Res Commun       Date:  2013-02-16       Impact factor: 3.575

Review 5.  The Role of NFkB in Drug Addiction: Beyond Inflammation.

Authors:  S E Nennig; J R Schank
Journal:  Alcohol Alcohol       Date:  2017-03-09       Impact factor: 2.826

6.  Nerve growth factor β polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment.

Authors:  O Levran; E Peles; S Hamon; M Randesi; C Zhao; B Zhang; M Adelson; M J Kreek
Journal:  Pharmacogenomics J       Date:  2011-03-01       Impact factor: 3.550

7.  Crosstalk between delta opioid receptor and nerve growth factor signaling modulates neuroprotection and differentiation in rodent cell models.

Authors:  Dwaipayan Sen; Michael Huchital; Yulong L Chen
Journal:  Int J Mol Sci       Date:  2013-10-21       Impact factor: 5.923

Review 8.  Epigenetic Modulation of Opioid Receptors by Drugs of Abuse.

Authors:  Ke Zhang Reid; Brendan Matthew Lemezis; Tien-Chi Hou; Rong Chen
Journal:  Int J Mol Sci       Date:  2022-10-05       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.